Fang-ming C. Chen

Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

Journal: Journal of breast cancer

Published: April 09, 2026

Development of a Nomogram-Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ.

Development of a Nomogram-Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ.

Journal: The Kaohsiung journal of medical sciences

Published: March 05, 2026

Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer.

Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer.

Journal: Breast cancer (Dove Medical Press)

Published: February 01, 2026

Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer.

Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer.

Journal: International journal of medical sciences

Published: November 01, 2025

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

Journal: International journal of biological macromolecules

Published: October 27, 2025

Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue.

Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue.

Journal: Journal of translational medicine

Published: September 14, 2025

Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer.

Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer.

Journal: Cancer genomics & proteomics

Published: September 04, 2025

Long-term outcomes of adjuvant radiation in elderly Asians with early stage IIA breast cancer after breast-conserving surgery: a population-based study.

Long-term outcomes of adjuvant radiation in elderly Asians with early stage IIA breast cancer after breast-conserving surgery: a population-based study.

Journal: Breast cancer (Tokyo, Japan)

Published: August 01, 2025

Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence.

Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence.

Journal: Communications medicine

Published: February 11, 2025

Intraoperative radiation therapy (IORT) in Taiwanese breast cancer patients: factors influencing local relapse risk and disease-free survival.

Intraoperative radiation therapy (IORT) in Taiwanese breast cancer patients: factors influencing local relapse risk and disease-free survival.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Published: December 13, 2024

Reply to the Commentary: Effective minimal invasive strategy for mixed type gynecomastia using vacuum-assisted mastectomy and power-assisted liposuction.

Reply to the Commentary: Effective minimal invasive strategy for mixed type gynecomastia using vacuum-assisted mastectomy and power-assisted liposuction.

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Published: December 09, 2024

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Journal: International journal of biological macromolecules

Published: October 12, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026